Influenza Vaccine Market in United States and Forecast to 2022

DPI Research has announced the addition of the "United States Influenza Vaccine Market: Analysis and Market Forecast 2016 - 2022" report to its offering http://www.dpiresearch.com/report-details.php?P_ID=88

New Delhi, Delhi, December 2, 2016 /India PRwire/ -- United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022.

Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It provides essential insights into United States influenza vaccine market and forecast. It covers vaccination pattern, doses distribution, production and offers a clear view of the regulatory landscape. Additionally, the report includes insight of clinical trials, pipeline and promising vaccines in United States influenza vaccine market. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the influenza vaccine market such as Sanofi Pasteur, GSK, Seqirus, AstraZenecca and Protein Sciences Corporation. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of influenza vaccine market from 2011 to 2022. Other emerging players such as Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, and VaxInnate are making novel technology based influenza vaccine which is likely to affect the market share during the forecast period. The report also entails major drivers and barriers of influenza vaccine market.

Major and Promising Vaccine covered in the report are as follows:

1. Fluzone High-Dose
2. Fluzone Quadrivalent
3. Intradermal (ID) Trivalent
4. Vaxigrip
5. Fluarix Quadrivalent
6. Flulaval Quadrivalent
7. Fluenz Tetra
8. FluMist Quadrivalent
9. Flublok
10. VN-100
11. M-001
12. VAX-2012Q
13. TAK - 850
14. Flucelvax Quadrivalent
15. Afluria Quadrivalent
16. Agrippal
17. Fluad
18. Fluvirin
19. Fluvax

Key Companies Covered in the Report are as follows

1. Sanofi Pasteur
2. GlaxoSmithKline(GSK)
3. Seqirus
4. AstraZenecca
5. Protein Sciences Corporation
6. Novavax
7. Daiichi-Sankyo
8. Mitsubishi Tanabe Pharma
9. BiondVax Pharmaceuticals Ltd
10. VaxInnate

Notes to Editor

DPI Research & Marketing Solutions is a market research, social research and marketing company which delivers all the information required to solve business and marketing problems. DPI Research is a Business Solutions firm which offer bespoke syndicated research reports, custom research solutions, marketing services and social research across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insights for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Journalists and Bloggers
Visit India PRwire for Journalists for releases, photos, email alerts and customized feeds just for Media.

If you have any query regarding information in the press releases, please contact the company listed in the press release itself. Please do not call India PRwire, we will be unable to assist you with your inquiry.


DPI Research & Marketing Solutions recent press release(s)


Hawaii MCI Tourism Market Will Reach 1.3 Billion by 2022

DPI Market Research published a latest report titled"Hawaii Meetings, Conventions, Incentives (MCI) Tourism Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 - 2022" to its databases

$ 4 Billion Non Invasive Prenatal Testing Market: Global Demand, Growth Potential & Opportunity Outlook 2017 - 2021

DPI Research has announced the addition of the "Non-Invasive Prenatal Testing (NIPT) Market Analysis, Market Size, Test Analysis, Country Outlook, Growth Potential, Competitive Strategies and Forecasts, 2017 To 2021" report to their offering.

Global Epilepsy Drug Market to Reach USD 5.5 Billion by 2021

DPI Research has announced the addition of the "Epilepsy Drug Market & Forecast to 2021" report to its offering

United States Insulin Pump Market to Reach USD 4 Billion by 2022.

DPI Research has announced the addition of the "United States Insulin Pump Market & Forecast to 2022" report to its offering http://www.dpiresearch.com/report-details.php?P_ID=96

High Intensity Focused Ultrasound (HIFU) System Market & Opportunities to 2022

DPI Research has announced the addition of the "High Intensity Focused Ultrasound (HIFU) System Market by Manufacturers, Research Sites, Clinical Trials, Deals Type, Key Trends & Opportunities to 2022" report to its offering